By Chelsey Dulaney
Cardinal Health Inc. (CAH) on Thursday named Michael Kaufmann,
who heads the drug distributor's pharmaceutical unit, as the
company's chief financial officer.
Mr. Kaufmann will replace Jeffrey Henderson, who is retiring.
Mr. Kaufmann, who has led the company's pharmaceutical unit since
2009, will take over as CFO on Nov. 11.
Mr. Henderson, 49, will remain with company until August 2015 to
help with the transition.
Mr. Kaufmann will be replaced as chief executive of the
pharmaceutical segment by Jon Giacomin, current president of U.S.
pharmaceutical distribution.
Write to Chelsey Dulaney at chelsey.dulaney@wsj.com
Access Investor Kit for Cardinal Health, Inc.
Visit
http://www.companyspotlight.com/partner?cp_code=A591&isin=US14149Y1082
Subscribe to WSJ: http://online.wsj.com?mod=djnwires